Skip to main content

Table 1 Demographical and clinical characteristics of group I, group II, and group III

From: Influenza A (H1N1) virus infection and TNF-308, IL6, and IL8 polymorphisms in Egyptian population: a case–control study

ParametersGroup I (n = 50)Group II (n = 50)Group III (n = 50)p value
Age (years, mean ± SD)44.14 ± 7.3344.54 ± 7.3337.22 ± 6.330.001*
Sex (male/female%)(66%/34%)(44%/56%)(38%/62%)0.013*
HCV17 (34.0%)7 (14.0%) 0.019*
Renal disease9 (18.0%)3 (6.0%) 0.065
Respiratory disease20 (40.0%)8 (16.0%) 0.265
CVD10 (20.0%)11 (22.0%) 0.806
Hypertension9 (18.0%)11 (22.0%) 0.617
Cancer3 (6.0%)1 (2.0%) 0.307
Diabetes40 (80.0%)15 (30.0%) 0.624
TB13 (26.0%)2 (4.0%) 0.976
Smoking history11 (22.0%)19 (38.0%) 0.081
PaO239 (78.0%)27 (54.0%) 0.686
Mortality7 (14.0%)1 (2.0%) 0.027*
ICU40 (80.0%)29 (58.0%) 0.017*
Chest X-ray
 Infiltrate7 (14%)19 (38.0%) 0.012*
 Consolidation30 (60%)14 (28.0%) 0.003*
 Chest infection8 (16%)11 (22.0%) 0.601
 Others5 (10%)6 (12.0%) 0.976
 Fever48 (96%)30 (60%) 0.00*
 Cough39 (78%)19 (38.0%) 0.004*
 Sputum50 (100.0%)50 (100.0%) 1.000
 Sore throat45 (90)34 (68) 0.007*
 Headache35 (70)42 (84) 0.096
 Dyspnea10 (20)5 (10) 0.161
 Diarrhea15 (30)10 (18.5) 0.248
 Vomiting10 (20)2 (0.04) 0.0138
  1. SD standard deviation, CVD cardiac vascular disease, PaO2 partial pressure of oxygen, ICU intensive care unit, HCV hepatitis C virus
  2. *p values are significant